Search hospitals > Minnesota > Shakopee
Saint Francis Regional Medical Center
Claim this profileShakopee, Minnesota 55379
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
314 reported clinical trials
10 medical researchers
Summary
Saint Francis Regional Medical Center is a medical facility located in Shakopee, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Lung Cancer and other specialties. Saint Francis Regional Medical Center is involved with conducting 314 clinical trials across 472 conditions. There are 10 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park7 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
98 reported clinical trials
160 drugs studied
Daniel M. AndersonRegions Hospital4 years of reported clinical research
Expert in Cancer
Expert in Tumors
60 reported clinical trials
108 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
74 drugs studied
Pamala A. PawloskiPark Nicollet Clinic - Saint Louis Park5 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
19 drugs studied
Clinical Trials running at Saint Francis Regional Medical Center
Breast Cancer
Bladder Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Bladder Carcinoma
Gastric Cancer
Renal Cell Carcinoma
Multiple Myeloma
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Francis Regional Medical Center?
Saint Francis Regional Medical Center is a medical facility located in Shakopee, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Lung Cancer and other specialties. Saint Francis Regional Medical Center is involved with conducting 314 clinical trials across 472 conditions. There are 10 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.
Where is Saint Francis Regional Medical Center located?
**Saint Francis Regional Medical Center**
Location: 1455 St. Francis Ave, Shakopee, MN 55379
Directions: From US-169 S, take the exit onto Marschall Rd S. Turn left onto St. Francis Ave. The hospital will be on your right.
Who should I call to ask about financial aid or insurance network?
**Saint Francis Regional Medical Center - Financial Assistance and Insurance Inquiries**
- **Eligibility and Enrollment Department:** For financial assistance applications, eligibility for government health insurance programs, and discounts based on the Federal Poverty Level, contact us at:
- **Address:** 3628 E. Imperial Highway, Suite #104, Lynwood, CA 90262
- **Phone:** 888-874-2585
- **Billing Department:** For billing concerns or questions about a specific bill, please call:
- **Phone:** 612.262.9000 or 800.859.5077
- **Website:** Visit the Allina Health website for more information.
- **Self-Pay and Assistance:** To inquire about self-pay options or qualifying for assistance, call 952.428.2569.
- **Account Information:** For financial brochures in English and Spanish, call 888-247-0125.
Financial assistance is available to those who qualify.
What insurance does Saint Francis Regional Medical Center accept?
Saint Francis Regional Medical Center accepts a variety of insurance plans, such as Saint Francis Health Plans, PacificSource Medicare Advantage, Premera PersonalCare, Regence Accountable Health Networks, Uniform Medical Plan Plus, and United Healthcare Charter. It also participates in individual and family plans available on MNsure for in-network coverage. Note that insurance plan acceptance may vary by facility within the Saint Francis Health System.
What awards or recognition has Saint Francis Regional Medical Center received?
Saint Francis Regional Medical Center, located in Shakopee, Minnesota, is distinguished by the Patient Safety Excellence Awardâ„¢ and the Pulmonary Care Excellence Awardâ„¢. It has also earned national recognition for its exceptional stroke care.